Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-24 · accession 0001654954-22-007509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | 2022-05-24 | EDSA | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $1.80 | +2,000 | 569.8K | +0.4% | +$3,600 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-05-24 | P | A | 2,000 | $1.80 | 569,812 | D | — | — |